Stocks-LXRX-Lexicon Pharmaceuticals Inc

LXRX Lexicon Pharmaceuticals Inc

2.43 -0.04 (-1.62%)
Delayed Prices By NASDAQ, in USD Market Closed
Invest
Stocks-LXRX-Lexicon Pharmaceuticals Inc
LXRX Lexicon Pharmaceuticals Inc
Invest
8.56% Past Week
Created with Highcharts 4.2.7 /Highstock 4.2.7
Market Cap
458.6M
Day’s Range
2.39
-
2.45
52W Range
1.31
-
3.45
Volume (3M)
376.54K
Price-Earnings Ratio
12.52
Revenue
125K

Lexicon Pharmaceuticals Inc Latest News

View All
Results from Lexicon Pharmaceuticals Inc. (LXRX) show potentialResults from Lexicon Pharmaceuticals Inc. (LXRX) show potentialUS Post News6 days agoHow should investors view Lexicon Pharmaceuticals Inc. (LXRX)?How should investors view Lexicon Pharmaceuticals Inc. (LXRX)?US Post News23 days ago
Pinned Post
eToro Team
eToro
16 days ago
🎉 Here’s a little preview introducing 16 YEARS of INVESTING on eToro 😏🤑 With love, - The eToro Team youtu.be/UFYvpJxh2qA
How can eToro celebrate 16 years of Investing?
youtu.be
Celebrating 16 years of investing together 💚 #etoro16
Like CommentShare
Show more comments2 of 75
5 replies
null
.
Top Discussions
Mattia Cucci
Italy
about a month ago
it seems too early to reinvest in cryptocurrencies, for now I'm taking less risk and going into banking and pharmaceutical products $GS (Goldman Sachs Group Inc) $ADA $BTC $ENI.MI (Eni Energy Company) $LXRX (Lexicon Pharmaceuticals Inc)
Like CommentShare
1 reply
null
.
MarketUpdates
United Kingdom
2 months ago
Edited
$LXRX (Lexicon Pharmaceuticals Inc) Q4 2022 earnings report is expected to be released
28
FEB
REPORTS
Lexicon Pharmaceuticals Inc Q4 2022 earnings report is expected to be released after market open
Notify me
LXRX
LXRX
Lexicon Pharmaceuticals Inc
2.43
-0.04
(-1.62%)
Trade
LXRX
Lexicon Pharmaceuticals Inc
2.41
-0.04 (-1.62%)
Trade
Like CommentShare
MarketUpdates
United Kingdom
2 months ago
$LXRX (Lexicon Pharmaceuticals Inc) Q4 2022 earnings report is expected to be released
Like CommentShare
MarketUpdates
United Kingdom
3 months ago
Edited
$LXRX (Lexicon Pharmaceuticals Inc) Q3 2022 earnings report is expected to be released
3
NOV
REPORTS
Lexicon Pharmaceuticals Inc Q3 2022 earnings report released after market open
LXRX
LXRX
Lexicon Pharmaceuticals Inc
2.43
-0.04
(-1.62%)
Trade
LXRX
Lexicon Pharmaceuticals Inc
2.41
-0.04 (-1.62%)
Trade
Like CommentShare
MarketUpdates
United Kingdom
4 months ago
Edited
$LXRX (Lexicon Pharmaceuticals Inc) Q3 2022 earnings report is expected to be released
LXRX
Lexicon Pharmaceuticals Inc
2.41
-0.04 (-1.62%)
Trade
Like CommentShare

About Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals is a biopharmaceutical company with international operations. The company works to discover and develop precise medicines for serious, chronic conditions. Founded in 1995, the company has headquarters in The Woodlands, Texas. It is listed using the LXRX ticker on the NASDAQ GS stock market. Add the LXRX stock to your holdings to increase the diversity of your eToro portfolio.
87
Employees
The Woodlands, Texas, US
HQ
1995
Founded
Lonnel Coats
CEO
Show More
Med TechNASDAQ

Upcoming Earnings

28
FEB
REPORTS
Lexicon Pharmaceuticals Inc Q4 2022 earnings report is expected to be released after market open

Analyst Forecast

Consensus
Moderate Buy
Price Target
6.00
Based on 2 analysts who covered LXRX 

ESG: A New Source of Insight

What is an ESG Score?
This number is a measure of a company’s exposure to environmental, social, and governance risks. Influencing factors include energy efficiency, safety, social policies, and more. Learn More
Powered by ESG Book
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
43
Low
Industry 
Avg. 47 
31
Environment
44
Social
49
Governance

People Also Bought